EPZ-719
Based on 5 publication(s) in Google Scholar
EPZ-719 is a selective, orally effective SETD2 inhibitor with an IC50 value of 0.005 μM. EPZ-719 has anticancer activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.00%
- CAS. Nr.: 2697176-16-0
- Formel: C22H31FN4O3S
- Molecular Weight:450.57
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) EPZ-719
MoreAlle Histone Methyltransferase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
|
SETD2/KMT3A |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| KMS-11 | IC50 |
0.211 μM
Compound: 32; EPZ-719
|
Antiproliferative activity against human KMS-11 cells assessed as reduction in cell viability incubated for 14 days by LTP assay
Antiproliferative activity against human KMS-11 cells assessed as reduction in cell viability incubated for 14 days by LTP assay
|
[PMID: 34671445] |
In Vitro
EPZ-719 (14 days) can inhibit cell proliferation in KMS34 and KMS11 cells with IC50 values of 0.025 μM and 0.211 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.